A multicenter comparative study on the efficacy, safety, and acceptability of the contraceptive subdermal implants Norplant® and Norplant®-II

Contraception

Volumn 55, Issue 6, 1997, Pages 359-367

  Cravioto, Ma Del Carmen ^a   Alvarado, Gloria ^b   Canto De Cetina, Thelma ^c   Bassol, Susana ^d   Oropeza, Guillermo ^e   Santos Yung, Ricardo ^f   Valencia, Jaime ^g   Palma, Yolanda ^e   Fuziwara, José Luis ^a   Navarrete, Teresa ^a   Garza Flores, Josué ^a   Pérez Palacios, Gregorio ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^b UNIVERSIDAD JUÁREZ DEL ESTADO DE DURANGO   (Mexico)

^c UNIVERSIDAD AUTÓNOMA DE YUCATÁN   (Mexico)

^d UNIVERSIDAD AUTÓNOMA DE COAHUILA   (Mexico)

^e SECRETARÍA DE SALUD   (Mexico)

^f HOSPITAL GENERAL DR MANUEL GEA GONZÁLEZ   (Mexico)

^g Unidad de Investigación y Evaluación   (Mexico)

Author keywords

Long term contraception; Mexican women; Norplant implants; Norplant II implants; Progestin only contraceptives

Indexed keywords

LEVONORGESTREL; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL TRIAL; CONTRACEPTION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FOLLOW UP; HUMAN; IMPLANTATION; MAJOR CLINICAL STUDY; MEXICO; MULTICENTER STUDY; TRANSDERMAL DRUG ADMINISTRATION;

ADULT; CAPSULES; COHORT STUDIES; CONTRACEPTION; CONTRACEPTIVE AGENTS, FEMALE; DRUG IMPLANTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LEVONORGESTREL; PATIENT DROPOUTS; PATIENT SATISFACTION; PREGNANCY RATE; SAFETY; TIME FACTORS;

EID: 0343742544     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0010-7824(97)00045-0     Document Type: Article

References (18)

1. Secretaría de Salud. Encuesta Nacional sobre Fecundidad y Salud. Memoria de la reunión celebrada el 30 de septiembre de 1988. Impreso, p. 221.
2. Sivin I, Díaz S, Holma P, Alvarez-Sánchez F, Robertson DN. A four-year clinical study of Norplant implants. Stud Fam Plann 1983;14:184-91.
3. Sivin I. International experience with Norplant and Norplant-II contraceptive implants. Stud Fam Plann 1988;19:81-94.
4. Klavon SL, Grubb GS. Insertion site complications during the first year of Norplant use. Contraception 1990;41:27-37.
5. Grubb GS, Moore D, Anderson NG. Pre-introductory clinical trials of Norplant implants: a comparison of seventeen countries' experience. Contraception 1995; 52:287-96.
6. Indian Council for Medical Research. Phase III clinical trial with Norplant-II (two covered rods). Report on five years of use. Contraception 1993;48:120-32.
7. Pasquale SA, Brandeis V, Cruz RI, Kelly S, Sweeney M. Norplant contraceptive implants: rods versus capsules. Contraception 1987;36:305-16.
8. Olsson S-E, Odlind V, Johansson EDB, Sivin I. Contraception with Norplant implants and Norplant-2 implants (two covered rods). Results from a comparative study in Sweden. Contraception 1988;37:61-74.
9. Gu S, Du M, Zhang L, Liu Y, Wang S, Sivin I. A five-year evaluation of Norplant-II implants in China. Contraception 1994;50:27-34.
10. Armitage P. Statistical Methods in Medical Research. Oxford: Blackwell Scientific Publications, 1971.
11. Farley TMM. Life table methods for contraceptive research. Stat Med 1986;5:475-89.
12. Olsson SE, Odlind V, Johansson EDB, Nordstrom M-L. Plasma levels of levonorgestrel and free levonorgestrel index in women using Norplant implants or two covered rods (Norplant-2). Contraception 1987;35:215-28.
13. Darney PD, Atkinson E, Tanner S, MacPherson S, Hellerstein S, Alvarado A. Acceptance and perceptions of Norplant among users in San Francisco, USA. Stud Fam Plann 1990;21:152-60.
14. Zimmerman M, Haffey J, Crane E, et al. Assessing the acceptability of Norplant® implants in four countries: findings from focus group research. Stud Fam Plann 1990;21:92-103.
15. Frank ML, Poindexter AN, Cornin LM, Cox CA, Bateman L. One-year experience with subdermal contraceptive implants in the United States. Contraception 1993; 48:229-43.
16. Moore LL, Valuck R, McDougall C, Fink W. A comparative study of one-year weight gain among users of medroxyprogesterone acetate, levonorgestrel implants, and oral contraceptives. Contraception 1995;52:215-20.
17. World Health Organization. Task Force on Long-acting Systemic Agents for Fertility Regulation. Special Programme of Research, Development and Research Training in Human Reproduction. A multicentred phase III comparative study of two hormonal contraceptive preparations given once-a-month by intramuscular injection: I. Contraceptive efficacy and side effects. Contraception 1988;37:1-20.
18. World Health Organization. Multinational comparative clinical trial of long-acting injectable contraceptives: norethisterone enanthate given in two dosage regimens and medroxyprogesterone acetate. Final report. Contraception 1983;28:1-20.